Fusion Antibodies and BizCom Japan, a privately-held Japan-based trading and consulting company, continue to strengthen ties with Fusion’s Director Paul Kerr attending BioJapan 2016 with BizCom Japan’s Director Hiroyasu Nakatani.
BizCom Japan Inc. has been engaged in sales and marketing of research reagents, services and equipment to the life science research market in Japan and consulting for innovative biotech companies in Japan as well as other countries, and has extensive experience in establishing various types of alliances with Japanese companies and public institutions.
BizCom Japan, Inc. use this experience and its sales and marketing expertise to exclusively market services and products of Fusion Antibodies in Japan.
To find out more information about BizCom Japan, please visit http://www.bizcomjapan.com
To find out more information about BioJapan 2016, please visit http://www.ics-expo.jp/biojapan